The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Human Osteoclast-Poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) Mutations
Open accessAbstract
Autosomal-Recessive Osteopetrosis (ARO) comprises a heterogeneous group of bone diseases for which mutations in five genes are known as causative. Most ARO are classified as osteoclast-rich, but recently a subset of osteoclast-poor ARO has been recognized as due to a defect in TNFSF11 (also called RANKL or TRANCE, coding for the RANKL protein), a master gene driving osteoclast differentiation along the RANKL-RANK axis. RANKL and RANK (coded for by the TNFRSF11A gene) also play a role in the immune system, which raises the possibility that defects in this pathway might cause osteopetrosis with immunodeficiency. From a large series of ARO patients we selected a Turkish consanguineous family with two siblings affected by ARO and hypogammaglobulinemia with no defects in known osteopetrosis genes. Sequencing of genes involved in the RANKL downstream pathway identified a homozygous mutation in the TNFRSF11A gene in both siblings. Their monocytes failed to differentiate in vitro into osteoclasts upon exposure to M-CSF and RANKL, in keeping with an osteoclast-intrinsic defect. Immunological analysis showed that their hypogammaglobulinemia was associated with impairment in immunoglobulin-secreting B cells. Investigation of other patients revealed a defect in both TNFRSF11A alleles in six additional, unrelated families. Our results indicate that TNFRSF11A mutations can cause a clinical condition in which severe ARO is associated with an immunoglobulin-production defect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to “osteoclast-rich” OPT, active bone formation is lacking in “osteoclast-poor” OPT (due to TNFRSF11A mutations226) or dysosteosclerosis (DSS) (an OPT of unknown etiology227).”
From Bone remodeling: an operational process ensuring survival and bone mechanical competence (2022) · cites this paper as [226]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
The molecular understanding of osteoclast differentiation
Asagiri, M., & Takayanagi, H. (2007) · Bone · doi:10.1016/j.bone.2006.09.023 · Cited by 1,363
Loss of the ClC-7 Chloride Channel Leads to Osteopetrosis in Mice and Man
Kornak, U., Kasper, D., Bösl, M. R., Kaiser, E., Schweizer, M., Schulz, A., Friedrich, W., Delling, G., & Jentsch, T. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00206-9 · Cited by 995
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling
Döffinger, R., Smahi, A., Chable-Bessia, C., Geissmann, F., Feinberg, J. M., Durandy, A., Bodemer, C., Kenwrick, S., Dupuis‐Girod, S., Blanche, S., et al. (2001) · Nature Genetics · doi:10.1038/85837 · Cited by 842
Self-citationFrattini, A., Orchard, P. J., Sobacchi, C., Giliani, S. C., Abinun, M., Mattsson, J. P., Keeling, D. J., Andersson, A., Wallbrandt, P., Zecca, L., et al. (2000) · Nature Genetics · doi:10.1038/77131 · Cited by 669
Self-citationTolar, J., Teitelbaum, S. L., & Orchard, P. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040952 · Cited by 500
Self-citationRossi, S. W., Kim, M., Leibbrandt, A., Parnell, S. M., Jenkinson, W. E., Glanville, S. H., McConnell, F. M., Scott, H. S., Penninger, J. M., Jenkinson, E. J., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062497 · Cited by 491
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis
Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., Macpherson, H. K., Wallace, R. G. H., Hul, W. V., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 484
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL
Sobacchi, C., Frattini, A., Guerrini, M. M., Abinun, M., Pangrazio, A., Susani, L., Bredius, R. G. M., Mancini, G. M. S., Cant, A. J., Bishop, N. J., et al. (2007) · Nature Genetics · doi:10.1038/ng2076 · Cited by 389
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 308
The unbearable lightness of bone marrow homeostasis
Agas, D., Marchetti, L., Douni, E. K., & Sabbieti, M. G. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.12.004 · Cited by 33
Rapid phenotyping of knockout mice to identify genetic determinants of bone strength
Freudenthal, B., Logan, J. G., _, _., Croucher, P. I., Williams, G. R., & Bassett, J. H. D. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0258 · Cited by 32
Bone phenotypes in rheumatology – there is more to bone than just bone
Thudium, C. S., Nielsen, S. H., Sardar, S., Mobasheri, A., van Spil, W. E., Lories, R. J. U., Henriksen, K., Bay‐Jensen, A., & Karsdal, M. A. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-03804-2 · Cited by 33
Mégarbané, A., Pangrazio, A., VILLA, A. M., Chouery, É., Maarrawi, J., Sabbagh, S., Lefranc, G., & Sobacchi, C. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.10.010 · Cited by 31
Self-citationSchena, F., Menale, C., Caci, E., Diomede, L., Palagano, E., Recordati, C., Sandri, M., Tampieri, A., Bortolomai, I., Capo, V., et al. (2017) · Stem Cells · doi:10.1002/stem.2574 · Cited by 30
Self-citationClézardin, P. (2011) · Bulletin du Cancer · doi:10.1684/bdc.2011.1398 · Cited by 34
Frederiksen, A. L., Larsen, M. J., Brusgaard, K., Novack, D. V., Knudsen, P. J. T., Schrøder, H. D., Qiu, W., Eckhardt, C. M., McAlister, W. H., Kassem, M. S., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2590 · Cited by 29
Papa, R., Picco, P. P., & Gattorno, M. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.11.001 · Cited by 27
Dysosteosclerosis is also caused by TNFRSF11A mutation
Guo, L. Z., Elcioglu, N. H., Pekuz, Ö. K. K., Topkar, O. M., Wang, Z., Sakamoto, Y., Matsumoto, N., Miyake, N., Nishimura, G., & Ikegawa, S. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0447-6 · Cited by 27
Osteoclast Activation and Inflammatory Bone Diseases: Focusing on Receptors in Osteoclasts
Zhao, W., Li, J., Su, T., Wang, C., Fu, Y., Li, C., Hua, P., Liang, X., Zhu, Y., & Cui, H. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s507269 · Cited by 28
Severe neuronopathic autosomal recessive osteopetrosis due to homozygous deletions affecting OSTM1
Ott, C., Fischer‐Zirnsak, B., Schröter, P., Richter, R., Gupta, N., Verma, N., Kabra, M., Mundlos, S., Rajab, A., Neitzel, H., et al. (2013) · Bone · doi:10.1016/j.bone.2013.04.007 · Cited by 26
Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats
Zhang, Z., Bai, D., Liu, M.-J., Li, Y., Pan, J., Liu, H., Wang, W., Xiang, L., Xiao, G. G., & Ju, D. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318265e7dd · Cited by 26
Cappariello, A., Paone, R., Maurizi, A., Capulli, M., Rucci, N., Muraca, M., & Teti, A. M. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.033 · Cited by 27
Boudin, E., & Hul, W. V. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.06.003 · Cited by 29
Unveiling the mysteries of the genetics of osteoporosis
Alonso, N., & Ralston, S. H. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0149-7 · Cited by 25
Shamriz, O., Shaag, A., Yaacov, B., NaserEddin, A., Weintraub, M., Elpeleg, O. N., & Stepensky, P. (2016) · Clinical Genetics · doi:10.1111/cge.12804 · Cited by 25
Wu, N., Liu, B., Du, H., Zhao, S., Li, Y., Cheng, X., Wang, S., Lin, J., Zhou, J., study, D. D. I. S. A. C. (., et al. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.06.006 · Cited by 28
Whyte, M. P., Campeau, P. M., McAlister, W. H., Roodman, G. D., Kurihara, N., Nenninger, A. R., Duan, S., Gottesman, G. S., Bijanki, V. N., Sedighi, H., et al. (2020) · Bone · doi:10.1016/j.bone.2020.115364 · Cited by 24
Genetic disorders associated with the RANKL/OPG/RANK pathway
Xue, J., Ikegawa, S., & Guo, L. Z. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01148-4 · Cited by 25
Sobacchi, C., Pangrazio, A., López, A. G.-M., Pascual‐Vaca, D., Caldana, M. E., Susani, L., Vezzoni, P., & VILLA, A. M. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2203 · Cited by 24
Self-citationDiagnosis and management of pediatric metabolic bone diseases associated with skeletal fragility
Charoenngam, N., Cevik, M. B., & Holick, M. F. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000914 · Cited by 23
Jules, J., Wang, S., Shi, Z., Liu, J., Shi, W., & Feng, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.667535 · Cited by 23
Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking
Liu, L., Wu, Y. M., Ye, K., Cai, M., Zhuang, G., & Wang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924197 · Cited by 22
Onal, M., Bishop, K. A., John, H. C. S., Danielson, A. L., Riley, E. M., Piemontese, M., Xiong, J., Goellner, J. J., O’Brien, C. A., & Pike, J. W. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2417 · Cited by 21
Human Genetics of Sclerosing Bone Disorders
Ridder, R. D., Boudin, E., Mortier, G. R., & Hul, W. V. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0439-7 · Cited by 23
A missense mutation sheds light on a novel structure–function relationship of RANKL
Qiu, H., Qin, A., Cheng, T., Chim, S. M., Smithers, L., Chen, K., Song, D., Liu, Q., Zhao, J., Wang, C., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30045 · Cited by 23
EnsembleGASVR: a novel ensemble method for classifying missense single nucleotide polymorphisms
Rapakoulia, T., Theofilatos, K., Kleftogiannis, D., Likothanasis, S., Tsakalidis, A., & Mavroudi, S. P. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu297 · Cited by 22
Teti, A. M. (2012) · BoneKEy Reports · doi:10.1038/bonekey.2012.46 · Cited by 21
Hogendorf, A., Zieliński, M., Constantinou, M., Śmigiel, R. S., Wierzba, J., Wyka, K., Wędrychowicz, A., Jakubiuk‐Tomaszuk, A., Budzyńska, E., Piotrowicz, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742834 · Cited by 20
Sobacchi, C., VILLA, A. M., Schulz, A., & Kornak, U. (2016) · University of Washington, Seattle eBooks · Cited by 19
Self-citationAggarwal, S. (2013) · Gene · doi:10.1016/j.gene.2013.04.069 · Cited by 19
Disorders of mineral homeostasis in children and adolescents
Root, A. W., & Diamond, F. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00027-5 · Cited by 18
RANK Ligand Helps Immunity to Leishmania major by Skewing M2-Like Into M1 Macrophages
Rigoni, T. S., Vellozo, N. S., Cabral-Piccin, M. P., Fabiano-Coelho, L., Lopes, U. G., Filardy, A. A., DosReis, G. A., & Lopes, M. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00886 · Cited by 19
Role of RANKL Signaling in Bone Homeostasis
Sobacchi, C., Menale, C., Crisafulli, L., & Ficara, F. (2024) · Physiology · doi:10.1152/physiol.00031.2024 · Cited by 18
Self-citationTélétchéa, S., Stresing, V., Hervouet, S., Baud’huin, M., Heymann, M., Bertho, G., Charrier, C., Ando, K., & Heymann, D. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2170 · Cited by 18
Sobacchi, C., & Abinun, M. (2022) · Bone · doi:10.1016/j.bone.2022.116541 · Cited by 18
Self-citationThe Physiology and Pathophysiology of the Osteoclast
Peruzzi, B., & Teti, A. M. (2011) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-011-9086-6 · Cited by 19
High Bone Mass Disorders: New Insights From Connecting the Clinic and the Bench
Bergen, D. J. M., Maurizi, A., Formosa, M. M., McDonald, G. L. K., El‐Gazzar, A., Hassan, N., Brandi, M. L., Riancho, J. A., Rivadeneira, F., Ntzani, E., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4715 · Cited by 17
Braun, A., Shekhar, S., Levey, D. F., Straub, P., Kraft, J., Panagiotaropoulou, G., Heilbron, K., Awasthi, S., Hanna, R. M., Hoffmann, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53595-6 · Cited by 17
Xue, J., Wang, Z., Shinagawa, S., Ohashi, H., Otomo, N., Elcioglu, N. H., Nakashima, T., Nishimura, G., Ikegawa, S., & Guo, L. Z. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3805 · Cited by 15
Myasthenia gravis genome-wide association study implicates AGRN as a risk locus
Topaloudi, A., Zagoriti, Z., Flint, A. C., Martinez, M. B., Yang, Z., Tsetsos, F., Christou, Y.-P., Lagoumintzis, G., Yannaki, E., Zamba‐Papanicolaou, E., et al. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2021-107953 · Cited by 15
Osteopetrosis with micro-lacunar resorption because of defective integrin organization
Blair, H. C., Yaroslavskiy, B. B., Robinson, L. J., Mapara, M. Y., Pangrazio, A., Guo, L., Chen, K., Vezzoni, P., Tolar, J., & Orchard, P. J. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.58 · Cited by 16
Self-citationA case of infantile osteopetrosis: The radioclinical features with literature update
EL-Sobky, T. A., Elsobky, E. S., Sadek, I., Elsayed, S. M., & Khattab, M. F. (2015) · Bone Reports · doi:10.1016/j.bonr.2015.11.002 · Cited by 16
Hasan, O., Pathan, A. Z., Naqi, H., Aqueel, T., Hashmi, P., & Lakdawala, R. H. (2018) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2018.10.038 · Cited by 15
Phenotype-autosomal recessive osteopetrosis
Pillai, N. R., Aggarwal, A., & Orchard, P. J. (2022) · Bone · doi:10.1016/j.bone.2022.116577 · Cited by 15
Self-citationRapid Skeletal Turnover in a Radiographic Mimic of Osteopetrosis
Whyte, M. P., Madson, K. L., Mumm, S. R., McAlister, W. H., Novack, D. V., Blair, J., Helliwell, T. R., Stolina, M., Abernethy, L. J., & Shaw, N. J. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2289 · Cited by 14
New primary immunodeficiency diseases: context and future
Yu, J. E., Orange, J. S., & Demirdağ, Y. Y. (2018) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000699 · Cited by 14
Synonymous Mutations Add a Layer of Complexity in the Diagnosis of Human Osteopetrosis
Palagano, E., Susani, L., Menale, C., Ramenghi, U., Berger, M., Uva, P., Oppo, M., Vezzoni, P., VILLA, A. M., & Sobacchi, C. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2929 · Cited by 15
Self-citationMolecular Mechanisms of Craniofacial and Dental Abnormalities in Osteopetrosis
Ma, Y., Xu, Y., Zhang, Y., & Duan, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210412 · Cited by 13
Sclerosing Bone Dysplasias: Leads Toward Novel Osteoporosis Treatments
Fijałkowski, I., Boudin, E., Mortier, G. R., & Hul, W. V. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0220-5 · Cited by 13
Khalid, A. B., Goodyear, S. R., Ross, R. A., & Aspden, R. M. (2016) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2016.06.024 · Cited by 13
Osteoimmunology: memorandum for rheumatologists
Zhao, L., Huang, L., & Zhang, X. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5105-7 · Cited by 13
IL-10 Critically Modulates B Cell Responsiveness in Rankl−/− Mice
Marrella, V., Iacono, N. L., Fontana, E., Sobacchi, C., Sic, H., Schena, F., Sereni, L. P., Castiello, M. C., Poliani, P. L., Vezzoni, P., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401977 · Cited by 13
Self-citationDenosumab in postmenopausal osteoporosis: what the clinician needs to know
Lewiecki, E. M. (2009) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x09343221 · Cited by 13
Ishigaki, K., Sakaue, S., Terao, C. C., Luo, Y., Sonehara, K., Yamaguchi, K., Amariuta, T., Too, C. L., Laufer, V. A., Scott, I. C., et al. (2021) · medRxiv · doi:10.1101/2021.12.01.21267132 · Cited by 13
Jules, J., Chen, W., Feng, X., & Li, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.736009 · Cited by 12
RANKL-independent osteoclastogenesis in the SH3BP2 cherubism mice
Kittaka, M., Yoshimoto, T., Hoffman, H. T., Levitan, M. E., & Ueki, Y. (2020) · Bone Reports · doi:10.1016/j.bonr.2020.100258 · Cited by 12
Iwamoto, S. J., Rothman, M. S., Duan, S., Baker, J. C., Mumm, S. R., & Whyte, M. P. (2020) · Bone · doi:10.1016/j.bone.2020.115224 · Cited by 12
Hogendorf, A., Lipska-Ziętkiewicz, B. S., Szadkowska, A., Borowiec, M., Koczkowska, M., Trzonkowski, P., Dróźdż, I., Wyka, K., Limon, J., & Mlynarski, W. M. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12235 · Cited by 11
Cappariello, A., Berardi, A. C., Peruzzi, B., Fattore, A. D., Ugazio, A. G., Bottazzo, G. F., & Teti, A. M. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090715 · Cited by 11
The many roles of RANKL-RANK signaling in bone, breast and cancer
Schramek, D., & Penninger, J. M. (2011) · IBMS BoneKEy · doi:10.1138/20110512 · Cited by 11
On the Evolution and Contemporary Roles of Bone Remodeling
Kostenuik, P. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00037-6 · Cited by 11
TCIRG1 and SNX10 gene mutations in the patients with autosomal recessive osteopetrosis
Koçak, G., Güzel, B., Mıhçı, E., Küpesiz, O. A., Yalçın, K., & Manguoğlu, A. E. (2019) · Gene · doi:10.1016/j.gene.2019.02.088 · Cited by 11
DisMaNET: A network-based tool to cross map disease vocabularies
del Valle, E. P. G., García, G. L., Santamaría, L. P., Zanin, M., Menasalvas, E., & Rodríguez‐González, A. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106233 · Cited by 11
Boyce, B. F., Zuscik, M. J., & Xing, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00011-3 · Cited by 14
Buchbinder, D. K., Steward, C. G., Puthenveetil, G., Nugent, D. J., Hsieh, L., Kirov, I., Neudorf, S. M. L., & Soni, A. (2012) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2012.01758.x · Cited by 10
C/EBPα and PU.1 exhibit different responses to RANK signaling for osteoclastogenesis
Jules, J., Li, Y., & Chen, W. (2017) · Bone · doi:10.1016/j.bone.2017.05.009 · Cited by 11
Xue, J., Wang, Z., Smithson, S., Burren, C. P., Matsumoto, N., Nishimura, G., Ikegawa, S., & Guo, L. Z. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-00831-8 · Cited by 9
Mendelian Disorders of RANKL/OPG/RANK Signaling
Whyte, M. P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387829-8.00020-2 · Cited by 10
Mendelian Disorders of RANKL/OPG/RANK/NF-κB Signaling
Whyte, M. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00026-5 · Cited by 10
Dysosteosclerosis: Clinical and Radiological Evolution Reflecting Genetic Heterogeneity
Turan, S., Mumm, S. R., Alavanda, C., Kaygusuz, S. B., Tosun, B. G., Arman, A., Huskey, M., Güran, T., Duan, S., Bereket, A., et al. (2022) · JBMR Plus · doi:10.1002/jbm4.10663 · Cited by 9
Metabolic and Endocrine Abnormalities
Freese, K., & Leet, A. I. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8758-6_19-1 · Cited by 10
DeBose-Scarlett, E. M., Ressler, A. K., Friday, C. M., Prickett, K. K., Roberts, J. W., Gossage, J. R., & Marchuk, D. A. (2025) · Journal of Medical Genetics · doi:10.1136/jmg-2024-110569 · Cited by 9
How rare bone diseases have informed our knowledge of complex diseases
Johnson, M. L. (2016) · BoneKEy Reports · doi:10.1038/bonekey.2016.69 · Cited by 9
Novel mutation of TCIRG1 and clinical pictures of two infantile malignant osteopetrosis patients
Yuan, P., Yue, Z., Sun, L., Huang, W., Hu, B., Yang, Z., Hu, Y., Xiao, H., Shi, H., Zhou, Q., et al. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0228-6 · Cited by 9
Root, A. W., & Levine, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00020-8 · Cited by 9
Xue, J., Şimşek‐Kiper, P. Ö., Ütine, G. E., Li, Y., Wang, Z., Taşkıran, E. Z., Karaosmanoğlu, B., İmren, G., Göçmen, R., Nishimura, G., et al. (2021) · Journal of Human Genetics · doi:10.1038/s10038-020-00891-w · Cited by 8
A novel mutation in TNFRSF11A gene causes pediatric osteopetrosis: case report
Xu, Y. J., Yu, X., & Huang, M. (2021) · BMC Surgery · doi:10.1186/s12893-021-01266-4 · Cited by 8
Osteopetrosis: Gene-Based Nosology and Significance SLC29A3, Dysosteosclerosis
Turan, S. (2022) · Bone · doi:10.1016/j.bone.2022.116615 · Cited by 8
RANK/RANKL Signaling Pathway in Breast Development and Cancer
Pérez-Chacón, G., Santamarı́a, P. G., Redondo-Pedraza, J., & González‐Suárez, E. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-70875-6_16 · Cited by 9
Innovations thérapeutiques dans l’ostéoporose (anticorps antisclérostine et denosumab)
Quemerais, M. A., Kerlan, V., & Chabre, O. (2011) · Annales d Endocrinologie · doi:10.1016/s0003-4266(11)70005-1 · Cited by 8
Perdu, B., Odgren, P. R., Wesenbeeck, L. V., Jennes, K., MacKay, C. A., & Hul, W. V. (2009) · Calcified Tissue International · doi:10.1007/s00223-009-9229-7 · Cited by 7
Osteoclast Formation from Peripheral Blood of Patients with Bone-lytic Diseases
de Vries, T. J., & Everts, V. E. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9057-3 · Cited by 7
Boyce, B. F., Zuscik, M. J., & Xing, L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387829-8.00001-9 · Cited by 8
Rosillo, M. Á., la Paz, S. M., Abia, R., Castejón, M. L., Millán-Linares, M. C., Alarcón‐de‐la‐Lastra, C., Fernández‐Bolaños, J. G., & Muriana, F. J. G. (2020) · Food & Function · doi:10.1039/d0fo00433b · Cited by 8
Effects of RANKL inhibition on inflammation and immunity
Ferrari‐Lacraz, S., & Ferrari, S. (2009) · IBMS BoneKEy · doi:10.1138/20090369 · Cited by 6
A new familial sclerosing bone dysplasia
Chouery, É., Pangrazio, A., Frattini, A., VILLA, A. M., Wesenbeeck, L. V., Piters, E., Hul, W. V., Coxon, F. P., Schouten, T., Helfrich, M., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090733 · Cited by 6
Self-citationRANK receptor oligomerisation in the regulation of NFκB signalling
Das, S., Sepahi, I., Duthie, A., Clark, S., & Crockett, J. C. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0077 · Cited by 6
Self-citationOsteopetrosis in a neonatal donkey
Williamson, A., Stent, A. W., Milne, M., & Walmsley, E. A. (2016) · Australian Veterinary Journal · doi:10.1111/avj.12492 · Cited by 6
Zhang, X., Wei, Z., He, J., Wang, C., & Zhang, Z. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1386529 · Cited by 6
Osteoporosis Genes Identified by Genome-Wide Association Studies
Rivadeneira, F., & Uitterlinden, A. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00022-8 · Cited by 6
New mechanisms of osteopetrosis
Fattore, A. D., Capannolo, M., & Teti, A. M. (2009) · IBMS BoneKEy · doi:10.1138/20090358 · Cited by 6
Wang, C., Fan, M., Heo, S., Adams, S. M., Li, T., Liu, Y., Li, Q., Loebel, C., Burdick, J. A., Lu, X. L., et al. (2025) · Advanced Science · doi:10.1002/advs.202414750 · Cited by 6
VILLA, A. M., Pangrazio, A., Caldana, E., Guerrini, M. M., Vezzoni, P., Frattini, A., & Sobacchi, C. (2008) · Cytotechnology · doi:10.1007/s10616-008-9165-9 · Cited by 5
Self-citationZulf Mughal, M. (2009) · Endocrine development · doi:10.1159/000223696 · Cited by 5
Haematopoietic Stem Cell Transplantation in Autosomal Recessive Osteopetrosis
Teti, A. M., & Schulz, A. (2013) · CRC Press eBooks · doi:10.1201/b14590-19 · Cited by 5
Early treatment of osteopetrosis: Paradigm shift to marrow cell transplantation
Teti, A. M. (2022) · Bone · doi:10.1016/j.bone.2022.116512 · Cited by 5
Pattern recognition receptor ligand-induced differentiation of human transitional B cells
McMillan, J. K. P., O'Donnell, P. J., & Chang, S. P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273810 · Cited by 5
Where is bone science taking us?
Langdahl, B. L., Uitterlinden, A. G., & Ralston, S. H. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101791 · Cited by 5
Neonatal hydrocephalus: an atypical presentation of malignant infantile osteopetrosis
Lee, A., Cortez, S., Yang, P. H., Aum, D. J., Singh, P., Gooch, C. F., & Smyth, M. D. (2021) · Child s Nervous System · doi:10.1007/s00381-021-05345-y · Cited by 5
Metadata
- Authors
- Guerrini, M. M., Sobacchi, C., Cassani, B., Abinun, M., Kilic, S. S., Pangrazio, A., Moratto, D., Mazzolari, E., Clayton-Smith, J., Orchard, P., Coxon, F. P., Helfrich, M. H., Crockett, J. C., Mellis, D., Vellodi, A., Tezcan, I., Notarangelo, L. D., Rogers, M. J., Vezzoni, P., Villa, A., & Frattini, A.
- Affiliations
- Institute of Biomedical Technologies (IT)
- IRCCS Humanitas Research Hospital (IT)
- Newcastle University (GB)
- University of Brescia (IT)
- University of Minnesota (US)
- University of Aberdeen (GB)
- Great Ormond Street Hospital (GB)
- Harvard University (US)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Corresponding author
- Villa, Anna
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 83
- Issue
- 1
- Pages
- 64-76
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC2443850
- OpenAlex
- W2040034328
- Cited by
- 309
- References
- 23
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 8 · 2023: 2 · 2022: 17 · 2021: 12 · 2020: 24 · 2019: 19 · 2018: 11 · 2017: 21 · 2016: 17 · 2015: 17 · 2014: 24 · 2013: 18 · 2012: 24
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Bursa Uludag University - AVESIS (submittedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Research Explorer (The University of Manchester) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- E-Rare
- Fondazione Telethon
- Fondazione Cariplo
- Ministero dell’Istruzione, dell’Università e della Ricerca (RBIN04CHXT)
- Army Research Office
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- osteopetrosis, RANK, RANKL, hypogammaglobulinemia, osteoclastogenesis, B cell defect, immunodeficiency, consanguinity, autosomal recessive osteopetrosis, macrophage colony-stimulating factor, monocytes
- MeSH terms
- Tartrate-Resistant Acid Phosphatase, Acid Phosphatase, Actins, Agammaglobulinemia, Amino Acid Sequence, Argentina, Arginine, Biopsy, Cell Line, Transformed, Cell Transformation, Viral, Cells, Cultured, Consanguinity, Cysteine, Dendrites, DNA Mutational Analysis, Herpesvirus 4, Human, Female, Genes, Recessive, Heterozygote, Homozygote, Humans, Ilium, Isoenzymes, Leukocytes, Mononuclear, Lipopolysaccharides, Male, Molecular Sequence Data, Osteoclasts, Osteopetrosis, Pakistan, Pedigree, Polymorphism, Genetic, Radiography, Thoracic, Turkey, Cohort Studies, Case-Control Studies, Macrophage Colony-Stimulating Factor, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Leukocyte Common Antigens, Models, Immunological, Receptors, Vitronectin, Amino Acid Substitution, Mutation, Missense, Cell Proliferation, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review